NGNE
Neurogene Inc
27.80$
-2.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -126.3% | – | – | – | – | – | -7,632.8% | – | |
| – | – | – | – | – | – | – | – | – | – | 351.0% | – | |
| – | – | – | – | – | – | – | – | – | – | 899.5% | – | |
| – | – | – | – | -21.7% | – | – | – | – | – | -644.4% | – | |
| – | – | – | – | 0.2% | – | – | – | – | – | 87.4% | – | |
| – | – | – | – | 223.8% | – | – | – | – | – | -13,541.7% | – | |
| – | – | – | – | – | – | – | – | – | – | -5.6% | – | |
| – | – | – | – | 2.3% | – | – | – | – | – | 19,899.6% | – | |
| – | – | – | – | 99.6% | – | – | – | – | – | -1,274.9% | – | |
| – | – | – | – | -126.5% | – | – | – | – | – | -7,720.1% | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.